Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMC Entertainment Holdings
AMC
|
+$36.2M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$16.5M |
| 3 |
McDonald's
MCD
|
+$14.5M |
| 4 |
Sinclair Inc
SBGI
|
+$12.6M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Independence Realty Trust
IRT
|
+$8.78M |
| 2 |
AbbVie
ABBV
|
+$8.19M |
| 3 |
Visa
V
|
+$8.05M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$7.33M |
| 5 |
Keurig Dr Pepper
KDP
|
+$7.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.78% |
| 2 | Technology | 13.29% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Applied Materials
AMAT
$391B
| $564K | 0.06% |
14,511
+1,934
| +15% | +$69.5K |
|
|
NEX
352
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $564K | 0.06% |
+39,422
| New | +$730K |
|
353
Omeros
OMER
$1.39B
| $559K | 0.06% |
+36,944
| New | +$404K |
|
354
Danaher
DHR
$154B
| $544K | 0.05% |
+7,173
| New | +$534K |
|
355
Alibaba
BABA
$286B
| $539K | 0.05% |
+4,995
| New | +$508K |
|
356
Celanese
CE
$5.14B
| $539K | 0.05% |
+6,008
| New | +$525K |
|
357
FNB Corp
FNB
$6.6B
| $535K | 0.05% |
+35,981
| New | +$552K |
|
358
Norfolk Southern
NSC
$78.8B
| $535K | 0.05% |
4,780
+2,720
| +132% | +$318K |
|
359
Voya Financial
VOYA
$8.86B
| $534K | 0.05% |
+14,077
| New | +$567K |
|
360
Zoetis
ZTS
$32.1B
| $522K | 0.05% |
+9,781
| New | +$529K |
|
361
First American
FAF
$7.33B
| $519K | 0.05% |
+13,201
| New | +$505K |
|
|
JCP
362
DELISTED
J.C. Penney Company, Inc.
JCP
| $518K | 0.05% |
84,042
-206,505
| -71% | -$1.37M |
|
363
Copa Holdings
CPA
$5.88B
| $517K | 0.05% |
+4,607
| New | +$469K |
|
|
TBRG
364
DELISTED
TruBridge
TBRG
| $512K | 0.05% |
+18,300
| New | +$459K |
|
|
ITCI
365
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $504K | 0.05% |
+30,989
| New | +$448K |
|
|
SJR
366
DELISTED
Shaw Communications Inc.
SJR
| $503K | 0.05% |
+24,258
| New | +$509K |
|
|
ZNGA
367
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $503K | 0.05% |
176,369
-180,715
| -51% | -$486K |
|
368
Cummins
CMI
$80.9B
| $495K | 0.05% |
3,274
-165
| -5% | -$24.4K |
|
369
TherapeuticsMD
TXMD
$23.8M
| $495K | 0.05% |
1,373
-569
| -29% | -$176K |
|
370
Watsco Inc
WSO
$12.9B
| $495K | 0.05% |
+3,460
| New | +$518K |
|
371
Henry Schein
HSIC
$9.86B
| $492K | 0.05% |
+7,380
| New | +$479K |
|
372
Baidu
BIDU
$31.6B
| $490K | 0.05% |
+2,839
| New | +$500K |
|
373
Northrop Grumman
NOC
$78.3B
| $490K | 0.05% |
2,060
-3,499
| -63% | -$831K |
|
|
MDCO
374
DELISTED
Medicines Co
MDCO
| $489K | 0.05% |
10,000
+3,485
| +53% | +$159K |
|
375
Carter's
CRI
$1.31B
| $475K | 0.05% |
+5,283
| New | +$455K |
|
Similar funds
Steve Schonfeld's Q1 2017 Portfolio in Review
As of Q1 2017, Steve Schonfeld held 843 positions worth $998M, up 29% from $772M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $186M of net new capital in Q1 2017, opening 316 new positions and adding to 131 existing holdings. Its largest new stake was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $8.19M trimmed.
- Steve Schonfeld's largest Q1 2017 buy was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
- Steve Schonfeld added most to Athene Holding Ltd. Class A Common Shares in Q1 2017, an estimated $16.5M increase.
- Steve Schonfeld's biggest Q1 2017 reduction was AbbVie, cutting an estimated $8.19M.
- Steve Schonfeld fully exited Independence Realty Trust in Q1 2017, selling an estimated $8.78M.
- Steve Schonfeld's ten largest holdings make up 15% of its $998M portfolio in Q1 2017.
- Steve Schonfeld opened 316 new positions and closed 270 in Q1 2017.
- Steve Schonfeld's portfolio value rose 29% quarter-over-quarter to $998M.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.